Literature DB >> 20946349

Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome.

J Curtis Nickel1, Daniel A Shoskes.   

Abstract

• Our traditional approach to managing the chronic prostatitis (CP) syndromes has not been very successful for many of our patients. • Our developing understanding of CP/chronic pelvic pain syndrome (CP/CPPS) as a heterogeneous syndrome rather than a homogenous disease has allowed us to develop treatment strategies based on individual patient characteristics. • By considering each patient as a unique individual and tailoring treatments to a specific patient's clinical 'phenotype' we improve our therapeutic outcomes.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20946349     DOI: 10.1111/j.1464-410X.2010.09701.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  Prostatitis.

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 2.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

3.  Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada.

Authors:  J Curtis Nickel; Dean Tripp; Allan Gordon; Michel Pontari; Daniel Shoskes; Kenneth M Peters; Ragi Doggweiler; Andrew Paul Baranowski
Journal:  Rev Urol       Date:  2011

4.  Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48:13-18.

Authors:  Dino Papeš; Miram Pasini; Ana Jerončić
Journal:  Int Urol Nephrol       Date:  2016-07-05       Impact factor: 2.370

Review 5.  Pelvic floor therapies in chronic pelvic pain syndrome.

Authors:  Ragi Doggweiler; Adam F Stewart
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 6.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

7.  α-Blockers for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Update on Current Clinical Evidence.

Authors:  J Curtis Nickel; Naji Touma
Journal:  Rev Urol       Date:  2012

Review 8.  Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact.

Authors:  J Curtis Nickel; Daniel A Shoskes; Florian M E Wagenlehner
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

9.  Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.

Authors:  Vittorio Magri; Emanuela Marras; Antonella Restelli; Florian M E Wagenlehner; Gianpaolo Perletti
Journal:  Exp Ther Med       Date:  2014-12-19       Impact factor: 2.447

10.  Antimicrobial Resistance Pattern in Enterococcus faecalis Strains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis.

Authors:  Yumi Seo; Gilho Lee
Journal:  Korean J Urol       Date:  2013-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.